NCT04186988View on ClinicalTrials.gov

[18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed Therapy

EARLY_PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 5, 2019

Primary Completion Date

March 12, 2020

Study Completion Date

March 12, 2020

Conditions
Advanced Lung Non-Small Cell CarcinomaMetastatic Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8Stage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8Stage IVB Lung Cancer AJCC v8
Interventions
DRUG

Fluorine F 18 Ara-G

Given IV

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

CellSight Technologies, Inc.

INDUSTRY

lead

University of California, Davis

OTHER